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Background: Low adherence to prescribed diabetes medications is one of the major reasons to poor glycemic
control in developing countries. Therefore, this study attempted to assess the magnitude of medication adherence
and factors associated with it among adult persons with diabetes in northwest Ethiopia.
Method: This study utilized a cross sectional study design with internal comparison. The study population was
adult persons with diabetes attending the Diabetes Referral Clinic of Gondar University Hospital. Adherence was
assessed using the eight-item Morisky Medication Adherence Scale (MMAS-8). In addition laboratory tests and chart
reviews were carried out to collect relevant data. Ordinary logistic regression was used to identify factors associated
with adherence.
Result: A total of 391 patients were studied. Based on the MMAS-8 scale, the self-reported adherence to diabetic
medication was low for 25.4% [95% CI: 21, 29] of the patients, medium for 28.7% [95% CI: 24, 33], and high for
45.9% [95% CI: 41, 50] of the patients. The Mean (±SD) of glycosylated hemoglobin for the low adherence group
was 8.2% (±2.1). It was 8.1% (±2.0), for the medium, and 7.4% (±1.6) for the high adherence group. In the
multivariate analysis poor wealth status (AOR = 1.99; 1.15, 3.43), using traditional treatment (AOR = 2.90; 1.03, 8.15),
and service dissatisfaction (AOR = 2.23; 1.04, 4.80) were significantly associated with low adherence to prescribed
diabetic medications.
Conclusion: Over half of the persons with diabetes did not adhere to medications. Adherence was poor among
users of traditional treatment and those dissatisfied with services. Developing a more intensive communication
strategies and improving the quality of services could improve the level of adherence.
Keywords: Low-adherence; HbA1c; Poor glycemic control; Traditional medicineBackground
Poor treatment adherence that contributes to subopti-
mal glycemic control continues to be one of the major
barriers to effective diabetes management. The World
Health Organization has reported that as many as fifty
percent of the patients with chronic diseases do not take
their medications as prescribed (Brown and Bussell
2011; Reynolds et al. 2004). Effective and successful glu-
cose control requires appropriate and timely use of
medication over the entire period of treatment, which is
often lifelong. Different studies have shown that adher-
ence to diabetes treatment has been highly varied and* Correspondence: solomekonnen@yahoo.com
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in any medium, provided the original work is pmay range from 1.4 to 88.0% (Kalyango et al. 2008;
Raum et al. 2012; Sankar et al. 2013).
Low adherence to prescribed diabetes medications ac-
counts for 30% to 50% of treatment failures, leading to
worse treatment outcomes and which cause damages to
vital organs (Medicine ARftACoP 2011). Treatment fail-
ure is in turn associated with reduced treatment bene-
fits and can have a negative financial burden on both
individual patients and the society at large (Wroth and
Pathman 2006; DiMatteo et al. 2002). In fact, effective
diabetes management often needs coordinated quality
services (Tricco et al. 2012).
Previous studies showed that therapy with multiple
drugs, poor appointment keeping, poor patient-provider
communication, and low patient education were factors
which increased poor medication adherence. In addition,n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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culture and religious affiliations that influence on indi-
vidual medication behaviors (Peyrot and Rubin 1994;
Ciechanowski et al. 2001; Weinger et al. 2011; Rhee
et al. 2005; Balkrishnan et al. 2003; Collins-McNeil et al.
2012). Despite the fact that giving due recognition to
diabetes mellitus as one of the major health issues of the
middle age and the elderly necessitates the gathering of
relevant information on medication behaviors and fac-
tors associated thereof, studies on patient medication
adherence are very limited in Ethiopia (Collins-McNeil
et al. 2012; Ho et al. 2009; Wabe et al. 2011; Abebe et al.
2013). Such information is very helpful for improving ac-
cess and the quality of services. Thus, the objective of
the study was to determine the magnitude of medication
adherence and associated factors among adult persons
with diabetes.
Methods
This study utilized a cross-sectional hospital based de-
sign and was conducted at the Diabetic Clinic of the
University of Gondar Referral Hospital. Opened two de-
cades ago, the clinic was serving over 8,000 persons with
diabetes at the time of the study.
The study population comprised confirmed persons
with diabetes aged 18 years and older attending the
Diabetes Referral Clinic. Individuals with a follow-up
duration of less than twelve months were excluded in
order to avoid the immediate period following diagnosis
and to obtain adequate time for observing adherence
(Donnan et al. 2002). Sample size was determined using
two proportion formula considering a 95% confidence
level, power of 80%, and various factors that were
known to influence diabetes medication adherence, and
resulted in a sample size of 407 (Sabanayagam et al.
2009; Khattab et al. 2010). The follow-up record book
was used as a sampling frame to randomly select eli-
gible study subjects. Study participants were selected
using a systematic sampling procedure; every second
person aged 18 years and older who visited the Clinic in
the months of January and February 2013 was selected
into the study on a daily basis.
Data collection
Data were collected by interviewing eligible subjects
using a pretested structured questionnaire. Data collec-
tors were trained laboratory technicians and nurses. The
questionnaire, which was administered in the local lan-
guage (Amharic), included questions that assessed dia-
betic risk factors, demographic characteristics, wealth
status, duration of diabetes, lifestyle, clinic attendance,
and drug regimen. We also gathered information on
self-perception by asking how satisfied they were with
the care they received at the current diabetic clinic (werated the responses on a three level scale as very dissat-
isfied, satisfied and very satisfied). In addition, physical
measurements were taken using standardized techniques
and calibrated equipment. Height was measured using a
stadiometer; participants stood in erect posture without
shoes. Body mass index (BMI) was calculated as the ra-
tio of weight in kilograms to the square of height in me-
ters. Waist girth was measured by placing a plastic tape
to the nearest 0.5 cm horizontally, midway between the
12th rib and iliac crest on the mid-axillary line. Hip cir-
cumference was measured around the widest portion of
the buttocks (Grundy et al. 2004).
Adherence was assessed using the eight-item Morisky
medication adherence scale (which asked, Do you some-
times forget to take your pills? People sometimes miss
their medications for reasons other than forgetting?
Thinking over the past two weeks, were there any days
when you did not take your medicine? Have you ever
cut back or stopped taking your medication without tell-
ing your doctor because you felt worse when you took
it? When you travel or leave home, do you sometimes
forget to bring along your medication? Did you take
your medicine yesterday? When you feel like your DM is
under control, do you sometimes stop taking your medi-
cine? And taking medication everyday is a real incon-
venience for some people; do you ever feel hassled about
sticking to your treatment plan?) (Peyrot and Rubin
1994). Biochemical tests (HbA1c tests) were done for
each study participant.
Data management
Six laboratory technicians, four nurses, and two super-
visors were trained by the principal investigator to assist
during data collection. Biochemical tests (HbA1c) were
carried out using 902 Automatic Analyzer with Roche/
Hitachi kit following a minimum of 10 hours fasting
period. To ensure the quality of the interview and the
acquisition of quality data, random checks were carried
out by field supervisors and the principal investigator.
Data entry, cleaning, and coding were done using
Epi-info version 3.5.3.
Statistical analysis
Adherence was assessed using the eight-item Morisky
Medication Adherence Scale (MMAS-8). Accordingly, in-
dividuals were classified as low-adherence if the mean
score was less than 6, medium adherence if the mean
score was 6 and 7, and high adherence if the mean score
was 8 (Raum et al. 2012; Ho et al. 2009; Al-Qazaz et al.
2010). Glycemic control level was calculated using a Cut-
point HbA1c 7%. Thus, those who scored 7% or more
were coded as having poor glycemic control, and those
with HbA1c score less than 7% were coded as having good
glycemic control (Shalansky et al. 2004; Moreira et al.
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compared to the reference (medium wealth status) since
they are both risk for poor glycemic control.
Poor glycemic control proportions were computed for
both Type 1 and Type 2 persons with diabetes. Ordinary
logistic regression was applied to test the presence of asso-
ciation with three level outcome; low-adherence, medium
adherence and high Adherence. The results were consid-
ered statistically significant at P ≤ 0.05. The independent
variables were selected based on prior evidences in the lit-
erature and their effect in the current analysis; variables
with the P-value of <0.2 in the bivariate analysis were se-
lected for the model to ensure marginal confounders are
considered in the final analysis.
Ethical statement
The study protocol was approved by the IRB of the Uni-
versity of Gondar. Patients were recruited voluntarily and
informed written consent was obtained from each study
participant. For the sake of privacy and confidentiality no
personal identifiers, such as name, were collected.
Results
A sample of 407 persons with diabetes joined this study;
sixteen of them refused to participate yielding a response
rate of 96.01% (391 out of 407). Of these, 280 (71.6%)
were Type 2 diabetics. The Mean age (±SD) of the study
group was 50.4 (±15.2) years; 35.8 (±13.4) were Type 1
persons with diabetes, and 56.1 (±11.5) years Type 2 per-
sons with diabetes. The mean duration since diagnosis
with diabetes was 6.8 (±5.1) years.
Self-reported adherence to medication measure by
MMAS-8 scale was low for 25.4% [95% CI: 21, 29],
medium for 28.7% [95% CI: 24, 33], and high for 45.9%
[95% CI: 41, 50] of the study subjects (Figure 1).
Overall, about a third, 138 (35.4%), of the study sub-























Figure 1 Proportion of adherence by sex with 95% CI error bar amon
West Ethiopia, 2013.control was better achieved with improved medication
adherence, and those who reported high medication ad-
herence were more likely to have good glycemic control
(Table 1).
The multivariate ordinal logistic regression analysis
showed that people with poor wealth status (AOR = 1.99;
95% CI: 1.15, 3.43), those dissatisfied with clinic services
(AOR= 2.23: 95% CI: 1.04, 4.80), patients receiving nonin-
sulin regimen (AOR = 2.31; 95% CI: 1.50, 3.47) and pa-
tients consulting traditional healers (AOR = 2.90; 95%
CI: 1.03, 8.15) were more likely to adhere poorly to dia-
betes medications (Table 2).
Discussion
This study uncovered that only about a third of the
persons with diabetes achieved a good glycemic control.
Patients who were more likely to demonstrate poor ad-
herence to prescribed diabetes medication were users of
traditional medication, receivers of noninsulin treatment,
persons with poor wealth status, and those dissatisfied
with services.
The proportion of low-adherence seen was comparable
with that of several other studies conducted in Sub-
Saharan Africa (Kalyango et al. 2008; Al-Qazaz et al. 2010;
Fedrick and Justin-Temu 2012; Teklay et al. 2013). How-
ever, lack of standard measurements and use of different
definitions make comparison challenging. It is important
for health care providers to consider low medication ad-
herence as a factor contributing to poor glycemic control
(Lau and Nau 2004). Thus, designing strategies to improve
medication adherence might improve glycemic control
and there-by decrease the rate of chronic complications
related to diabetes.
This study showed a significant association between
poor socio-economic status and low-adherence. These
findings are in agreement with other studies that showed
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Table 1 The relationship between adherence categories and glycemic control groups: the Morisky scale adherence
categories and glycemic control groups in Gondar University Referral Hospital (2013) Ethiopia
Glycemic level Low adherence (score < 75%) Medium adherence (score ≥ 75 < 100) High adherence (score = 100) P-value
Good control (HbA1c < 7% ) 28 (20.3%) 29 (21.0%) 81 (58.7%) P = 0.001
Poor control (HbA1c≥ 7%) 71 (28.2%) 83 (32.9%) 98 (38.9%)
Total 99 (25.4%) 112 (28.7%) 179 (45.9%)
A significant relationship between medication adherence and HbA1C categories (x2 = 14.22) was found.
Table 2 Multivariate ordinary logistic regression analysis of factors associated with low-adherence among person with
diabetes in Gondar Referral Hospital of Gondar, North West Ethiopia (2013)
Variable n Low to medium medication adherence n (%) Adjusted OR [95% CI]
Age in year
≤ 24 29 20 (68.9) 1.00
25–44 98 61 (62.2) 1.12 [0.51,2.46]
45–64 190 96 (50.5) 0.56 [0.25,1.24]
≥65 73 34 (46.6) 0.47 [0.19,1.14]
Sex
Female 207 102 (48.3) 0.73 [0.47,1.13]
Male 184 109 (59.6) 1.00
Wealth Index
Medium 118 55 (46.6) 1.00
Poor 135 79 (58.9) 1.99 [1.15,3.43]
Rich 138 77 (55.8) 1.56 [0.94,2.59]
Insulin treatment
No 192 115 (60.2) 2.31 [1.50,3.47]
Yes 199 96 (48.2) 1.00
Level of Education
Illiterate 143 69 (48.2) 1.00
Grad 1–6 50 25 (50.0) 1.04 [0.54,2.02]
Grad 7–12 120 65 (54.2) 1.29 [0.76,2.05]
Diploma and above 78 52 (67.5) 1.79 [0.94,3.43]
Transport
Waking 90 55 (61.1) 0.72 [0.45,1.14]
Bus 300 156 (52.0) 1.00
Reported using traditional medication
No 375 200 (53.3) 1.00
Yes 15 11 (73.3) 2.90 [1.03,8.15]
Service satisfaction level
Dissatisfied 36 21 (58.3) 2.23 [1.04,4.80]
Satisfaction 212 124 (58.5) 1.53 [1.03,2.34]
Highly satisfied 141 66 (46.8) 1.00
Health education
No 43 19 (44.2) 1.00
Yes 347 192 (55.3) 1.89 [0.97,3.70]
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in persons with diabetes (Raum et al. 2012; Wabe et al.
2011; Larranaga et al. 2005; Seligman and Schillinger
2010; Seligman et al. 2012). Individuals with low socioeco-
nomic status cannot access education, information, trans-
portation and obtain the required drugs on time. This may
increase patients’ difficulty to follow diabetes treatment
(Seligman et al. 2012; Drewnowski and Darmon 2005). If
the patient feels that the cost of therapy is a financial
burden, the compliance with therapy will definitely be
threatened causing low adherence (Jin et al. 2008).
An additional reason for patients’ low-adherence to dia-
betes treatment was their belief in traditional healers and
preference to use such treatment (Haque et al. 2005). Inte-
grating traditional and spiritual practices with modern
health care system is an area for further research as the
disease requires life-long care, perhaps from both systems
in developing countries (Mann et al. 2009). Chronic dis-
eases and their treatment is poorly understood within
traditional and faith based healing systems, and may thus
affect medication adherence (de-Graft Aikins et al. 2010).
Poor adherence can also be an active process whereby
patients choose to deviate from the treatment regimen
through a rational decision process in which they weigh
the risks and benefits of treatment against any adverse
effects (Raum et al. 2012; Rutebemberwa et al. 2013).
Failing to elicit the history of the use of alternative,
traditional, or supplemental therapy from patients due
to ineffective communication between the patient and
the health care provider would be a missed opportunity
to improve medication adherence (Brown and Bussell
2011). A doctor-patient relationship based on trust is
important to encourage patients to tell the health care
provider about alternative medicine they are using hon-
estly (Haque et al. 2005).
Dissatisfaction with the service received at the diabetic
clinic was significantly associated with low adherence. Sev-
eral reports have shown that service satisfaction is an im-
portant factor for good adherence among persons with
diabetes (Biderman et al. 2009; Kocarnik et al. 2012). Pa-
tients dissatisfied with services provided at clinics might
not be willing to attend the follow-up clinic. So dissatisfac-
tion could be a barrier to achieving high adherence level
and good glycemic control.
Our study showed that patients receiving noninsulin
treatment were more likely to adhere with treatment
compared to those receiving insulin treatments. This
finding is consistent with those of other studies that
showed lower adherence to oral medication agents
among Type 2 persons with diabetes (Brown and Bussell
2011; Wabe et al. 2011; Lin et al. 2004; Farsaei et al.
2011). Patients receiving insulin treatment are more
likely to take the disease more seriously, and are more
likely to be symptomatic while non-insulin treated Type2 persons with diabetes are usually asymptomatic (Tiv
et al. 2012).
One of the limitations of this study was that self-
reported medication adherence were used as a measure
of the level of adherence. Since the study was conducted
at a clinic setting, a social desirability bias might have
creeped in. However, during the orientation efforts were
made to explain about the aim of the study, the confi-
dentiality of the research process and its zero effect on
the services they are receiving. The Morisky medication
adherence scale has been a validated and one of the
most widely used self-reported measures of adherence.
Thus, it is unlikely that our estimates are seriously
underestimated.Conclusion
Low-adherence to medication regimens is common among
persons with diabetes and is substantially related to poor
glycemic control. Use of traditional medication and dissat-
isfaction with services were important factors associated
with low adherence. Since the above risks are modifiable
factors, addressing these risks through improving service
availability, enhancing family support, providing more in-
tensive communicative strategies and better health educa-
tion could improve the level of adherence.
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